SAFC BIOSCIENCES AND CHROMOS ANNOUNCE STRATEGIC ALLIANCE TO CO-MARKET ACE SYSTEM

SAFC Biosciences, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), and Chromos Molecular Systems Inc. ("Chromos"; TSX:CHR), have entered into a non-exclusive co-marketing arrangement whereby SAFC Biosciences and Chromos will jointly market and offer Chromos' proprietary ACE System for cell line engineering for protein production applications. This agreement adds to SAFC's process development service offerings for biopharmaceutical markets and expands Chromos' access to the global biopharmaceutical market with its ACE System.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/September2005/30/c5853.html)